These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15483073)

  • 1. Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy.
    Koutkia P; Canavan B; Breu J; Grinspoon S
    J Clin Endocrinol Metab; 2005 Jan; 90(1):32-8. PubMed ID: 15483073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
    Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
    J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.
    Koutkia P; Meininger G; Canavan B; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E296-303. PubMed ID: 14559725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy.
    Andersen O; Haugaard SB; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
    Scand J Infect Dis; 2004; 36(11-12):832-9. PubMed ID: 15764170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution.
    Koutkia P; Eaton K; You SM; Breu J; Grinspoon S
    AIDS; 2006 Apr; 20(6):855-62. PubMed ID: 16549969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.
    Hadigan C; Corcoran C; Piecuch S; Rodriguez W; Grinspoon S
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3544-50. PubMed ID: 11061499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
    Meininger G; Hadigan C; Laposata M; Brown J; Rabe J; Louca J; Aliabadi N; Grinspoon S
    Metabolism; 2002 Feb; 51(2):260-6. PubMed ID: 11833059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution.
    Brigante G; Diazzi C; Ansaloni A; Zirilli L; Orlando G; Guaraldi G; Rochira V
    Eur J Endocrinol; 2014 May; 170(5):685-96. PubMed ID: 24536088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
    Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
    JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.
    Haugaard SB; Andersen O; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
    Metabolism; 2004 Dec; 53(12):1565-73. PubMed ID: 15562401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls.
    Zirilli L; Orlando G; Carli F; Madeo B; Cocchi S; Diazzi C; Carani C; Guaraldi G; Rochira V
    Eur J Endocrinol; 2012 Mar; 166(3):415-24. PubMed ID: 22189998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents.
    Viganò A; Mora S; Brambilla P; Schneider L; Merlo M; Monti LD; Manzoni P
    AIDS; 2003 Jul; 17(10):1435-41. PubMed ID: 12824780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A; Cerbone G; Pivonello R; Aimaretti G; Loche S; Di Somma C; Faggiano A; Corneli G; Ghigo E; Lombardi G
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period.
    Perotti M; Perra S; Saluzzi A; Grassi G; Pincelli AI
    Horm Metab Res; 2013 Sep; 45(10):748-53. PubMed ID: 23913118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.